Utilization methods and advantages of morpholino chlorophosphoramidite.
Introduction to High Purity Morpholino Chlorophosphoramidite As gene therapy and antisense drug development open up new possibilities in medicine, the key to their success lies in the high-performance artificial nucleic acid known as Morpholino Oligomer (PMO). Sapala Organics combines years of expertise in nucleic acid chemistry with cutting-edge technology to provide high-quality Morpholino synthesis reagents that strongly support your next-generation oligonucleotide drug development. What is Morpholino? Morpholino Oligomer (PMO) is a type of artificial nucleic acid that replaces the sugar (ribose) backbone of natural nucleic acids with a Morpholino ring, and the ionic phosphodiester bond with a non-ionic phosphorodiamidate bond.
Inquire About This Product
basic information
For inquiries regarding quantity and quality, please contact us.
Price information
It varies depending on the synthesis scale. Please contact us.
Delivery Time
Applications/Examples of results
Morpholino chlorophosphoramidite exhibits excellent characteristics due to its unique chemical structure: - High in vivo stability: It is very resistant to degradation by nucleases (nucleic acid-degrading enzymes) and remains stable in the body for extended periods. - Strong and specific binding affinity: It binds strongly and specifically to the target mRNA, effectively suppressing gene expression by inhibiting its translation (antisense effect). - Excellent safety: Due to its lack of charge, it has fewer interactions with nonspecific proteins, and its safety is expected to be high. Because of these properties, morpholinos are being researched and developed worldwide as extremely promising molecules in the field of nucleic acid medicines, including antisense therapeutics.
catalog（1）
Download All Catalogs
Company information
Ayurveda is well-known, but historically, India has been significantly involved with "medicine." Sapala Organics was established in 2005 in Hyderabad, located in the central part of the Deccan Plateau. The state government is actively investing to make this area a "Pharma City" (a treasure trove of medicine). Sapala has gained recognition from major pharmaceutical companies in the United States and Europe, steadily achieving results. To further provide the technological capabilities developed globally to Japan, Sapala Corporation was established in February 2018 as a local subsidiary in Japan. Recently, the Japanese government has also been focusing on projects that promote advanced pharmaceutical development and drug discovery, including nucleic acid-related drugs. We encourage you to consider the technological expertise of "Sapala," which excels in these fields.
